Form 8-K - Current report:
SEC Accession No. 0001108205-26-000059
Filing Date
2026-05-12
Accepted
2026-05-12 16:01:42
Documents
13
Period of Report
2026-05-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cris-20260512.htm   iXBRL 8-K 29909
2 EX-99.1 a1q26earningspressrelease.htm EX-99.1 70133
6 image_0.jpg GRAPHIC 13933
  Complete submission text file 0001108205-26-000059.txt   247924

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cris-20260512.xsd EX-101.SCH 1789
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cris-20260512_lab.xml EX-101.LAB 22548
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cris-20260512_pre.xml EX-101.PRE 13054
16 EXTRACTED XBRL INSTANCE DOCUMENT cris-20260512_htm.xml XML 2821
Mailing Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421 617-503-6500
CURIS INC (Filer) CIK: 0001108205 (see all company filings)

EIN.: 043505116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30347 | Film No.: 26968303
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)